Brought to you by:

Cell & Gene Therapy

Explore news and insight around cell and gene therapy, including new technology and information in this evolving biotech field. Read on to understand how the industry is addressing gene therapy and cell therapy research and development.

Brought to you by:
dollar bills in multiple stacks
Biotech

RegenXBio sells $250M of paydays for Zolgensma, other therapies

RegenXBio will fill its coffers with up to $250 million by monetizing more royalty rights for Zolgensma as well as a gene therapy nearing approval.
James Waldron May 20, 2025 7:15am
red blood cells

CRISPR Tx, Sirius pen collab with a focus on thrombotic disease

May 20, 2025 3:59am
a lot of scissors

Gene editor shelves sole clinical asset, lays off 25% of staff

May 19, 2025 2:28pm
Close-up of human eye

Atsena gene therapy hits safety goals, closes retinal splits

May 19, 2025 12:59pm
gene therapy AAV adeno-associated viruses

Neurogene details death in Rett syndrome gene therapy trial

May 16, 2025 3:00pm
Rocket with heart on blue background

Rocket's gene therapy sets new efficacy bar in ph. 1 heart study

May 16, 2025 10:36am
More News

Lilly strengthens RNA pipeline with $1.3B hearing loss pact

May 16, 2025 7:34am

HCW Biologics clings on with $5M lifeline to fund alopecia trial

May 16, 2025 7:00am

Boy with rare disease 'thriving' after 1st custom gene therapy

May 15, 2025 1:00pm

Allogene lays off 28% of staff to save cash amid program delays

May 14, 2025 8:00am